BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Drug Development

  AB Science announced the continuation of the Phase 2 study evaluating masitinib in combination with isoquercetin in COVID-19, following the recommendation of the Data and Safety Monitoring Board (DSMB)

  AB Science SA announced the continuation of the Phase 2 study evaluating masitinib in combination with isoquercetin in COVID-19, following the recommendation of the Data and Safety Monitoring Board.

  April 28, 2022

   · 

  4 min read
• Drug Development

  Diadem Announces Publication of Peer-Reviewed Article Describing How Post-Translational Modifications of p53 Variants May Contribute to Development of Alzheimer’s Disease

  Diadem SpA announced release of a new peer-reviewed publication, Post-Translational Modifications of the p53 Protein and the Impact in Alzheimer’s Disease: A Review of the Literature, in the current issue of the journal Frontiers in Aging Neuroscience.

  April 28, 2022

   · 

  6 min read
• Business

  Angle PLC Announces Preliminary Results - Apr 28, 2022

  ANGLE plc, a world-leading liquid biopsy company, announces audited preliminary results for the year ended 31 December 2021.

  April 28, 2022

   · 

  5 min read
• Biovica Capital Markets Day Invitation May 17, 2022

  Biovica is approaching market launch of DiviTum®TKa in the US for the monitoring of metastatic breast cancer treatments.

  April 28, 2022

   · 

  2 min read
• Business

  Immunovia Publishes Interim Report January-March 2022

  Immunovia continues to build on its unique position as the front-runner in innovative early detection of pancreatic cancer.

  April 28, 2022

   · 

  7 min read
• Drug Development

  Alzinova announces positive safety review and continuation of its Phase 1b study in Alzheimer’s disease

  Alzinova AB announces that the Data and Safety Monitoring Board completed a planned assessment of the ongoing ALZ-101 Phase 1b clinical study and recommended continuation of the study.

  April 28, 2022

   · 

  3 min read
• Business

  Orexo Interim Report Q1 2022

  Christine Rankin and Michael J Matly were elected as Board members at the Annual General Meeting. They replace David Colpman and Kirsten Detrick who have declined re-election.

  April 28, 2022

   · 

  3 min read
• BioInvent Receives Milestone Payment from Bayer/Hope Medicine Licensing Agreement

  BioInvent International AB announces that it receives a milestone payment following clinical progression of an out-licensed antibody.

  April 28, 2022

   · 

  2 min read
• Business

  Medivir AB - Interim Report January - March 2022

  Momentum in several areas, not least the development of our cutting-edge project fostroxacitabine bralpamide.

  April 28, 2022

   · 

  6 min read
• Business

  Annual Report 2021 Active Biotech AB (publ)

  Active Biotech’s Annual Report 2021 is now available for download at www.activebiotech.com.

  April 28, 2022

   · 

  1 min read